Gilnature/iStock by way of Getty Images Pharmaceutical firm ARCA biopharma (NASDAQ:ABIO) stated on Friday its…
FibroGen CFO, CMO to leave company by 12 months’s end Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
In summary Gov. Gavin Newsom in 2020 signed a law allowing California to manufacture its…
Arcutis surges 18% as Mizuho highlights growth of Zoryve Source: Seekingalpha
Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha
